Gong S

No ORCID on file · 7 papers in corpus · active 2016-2026

Study types

  • article 1
  • review 1

Condition tags

  • dysmenorrhea 2
  • adenomyosis 1
2026
Cardiovascular Health in Women-Across the Lifespan.
Clinical endocrinology ·doi:10.1111/cen.70027

Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and …

review 2026
Modulation of Female Reproductive Functions through Nerve Growth Factor: A Systematic Review
Expert reviews in molecular medicine ·doi:10.1017/erm.2026.10050

BACKGROUND: Nerve growth factor (NGF), which acts on receptors tropomyosin receptor kinase A and p75 neurotrophic receptor, is a member of neurotrophin family and a kind of secretory polypeptides. METHODS: A comprehensive literature search…

2023
Mechanism and Pharmacodynamic Substance Basis of Raw and Wine-Processed Evodia rutaecarpa on Smooth Muscle Cells of Dysmenorrhea Mice.
Pain research & management ·doi:10.1155/2023/7711988

ObjectivesEvodia rutaecarpa (ER) is a well-known herbal Chinese medicine traditionally used for analgesia in dysmenorrhea, headaches, abdominal pain, etc. Notably, the analgesic effect of wine-processed Evodia rutaecarpa (PER) was more pote…

2023
The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma.
Heliyon ·doi:10.1016/j.heliyon.2023.e18016

To evaluate the role of serum human epididymis secretory protein 4 (HE4) and carbohydrate antigen 125 (CA125) levels for predicting and monitoring the recurrence of endometrial endometrioid carcinoma (EEC) and assessing preoperative risk st…

2022
Non-coding RNA-mediated high expression of SFXN3 as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer.
Frontiers in immunology ·doi:10.3389/fimmu.2022.920136

Chemoresistance is the leading cause of poor prognosis in head and neck squamous cell carcinoma (HNSC); however, promising biomarkers to identify patients for stratified chemotherapy are lacking. Sideroflexin 3 (SFXN3) is an important mitoc…

2021
Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma.
Scientific reports ·doi:10.1038/s41598-021-01263-w

There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma (EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) as the biomarkers to predict and monitor recurrence of…

article 2016
Outcomes in Adenomyosis Treated with Uterine Artery Embolization Are Associated with Lesion Vascularity: A Long-Term Follow-Up Study of 252 Cases
PloS one ·doi:10.1371/journal.pone.0165610

PURPOSE: To study the therapeutic effects of uterine artery embolization (UAE) on adenomyosis and to investigate the association between uterine blood supply and artery embolization treatment outcomes. METHODS: Using digital subtraction ang…